PhaseV
PrivateLast Round
Series A
May 13, 2025
Total Funding Raised
$65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PhaseV is a healthcare technology company that provides an AI and machine learning-driven platform to optimize clinical development for biopharma sponsors and contract research organizations.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PhaseV Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
PhaseV Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 13, 2025 | ||||
| Seed | Oct 24, 2023 |
Key People
Founding team and executive leadership
PhaseV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Viola Ventures | Series A, Seed |
| Exor | Series A |
| LionBird | Series A, Seed |
| Exor Ventures | Seed |
| Insight Partners | Series A |
| Accel | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2026
Launched new Enrollment Lab solution at the 17th Annual SCOPE Summit.
- Feb 2, 2026
Launched new Enrollment Lab solution for clinical development.
PhaseV Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PhaseV's valuation, stock price, and market status.